welbournes

/welbournes

About welbournes

This author has not yet filled in any details.
So far welbournes has created 452 blog entries.

National Patient Safety Alert: Class 1 Medicines Recall: Emerade 500 micrograms and Emerade 300 micrograms auto-injectors

National Patient Safety Alert: Class 1 Medicines Recall Notification: Recall of Emerade 500 micrograms and Emerade 300 micrograms auto-injectors, due to the potential for device failure. National Patient Safety Alert Reference Number: NatPSA/2023/004/MHRA Date issued: 9th May 2023 Emerade 500 micrograms solution for injection in pre-filled syringe, PL 33616/0015 (SNOMED Code 23420111000001107) Emerade 300 micrograms [...]

The post National Patient Safety Alert: Class 1 Medicines Recall: Emerade 500 micrograms and Emerade 300 micrograms auto-injectors appeared first on PSNC Website.

By |May 9th, 2023|Lexpos News|Comments Off on National Patient Safety Alert: Class 1 Medicines Recall: Emerade 500 micrograms and Emerade 300 micrograms auto-injectors

April 2023 Price Concessions Final Update

The Department of Health and Social Care (DHSC) has today (28/04/2023) granted the following final list of price concessions for April 2023: Drug Pack size Price concession Amoxicillin 125mg/5ml oral suspension 100 £3.46 Amoxicillin 125mg/5ml oral suspension sugar free 100 £3.29 Baclofen 5mg/5ml oral solution sugar free 300 £5.99 Benzoyl peroxide 5% / Clindamycin 1% [...]

The post April 2023 Price Concessions Final Update appeared first on PSNC Website.

By |April 28th, 2023|Lexpos News|Comments Off on April 2023 Price Concessions Final Update

MHRA Drug Safety Update April 2023

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 16 Issue 9 April 2023) has been published and includes articles on: Isotretinoin (Roaccutane▼): new safety measures to be introduced in the coming months. Janus kinase (JAK) inhibitors: new measures to reduce risks of major cardiovascular eventss, malignancy, venous thromboembolism, serious infections [...]

The post MHRA Drug Safety Update April 2023 appeared first on PSNC Website.

By |April 27th, 2023|Lexpos News|Comments Off on MHRA Drug Safety Update April 2023

Class 4 Medicines Defect Information: Beconase Hayfever Nasal Spray (Omega Pharma Ltd)

Class 4 Medicines Defect Information: Beconase Hayfever Nasal Spray (Omega Pharma Ltd) Drug alert number: EL (23)A/15 Date issued: 26 April 2023 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Product name:Beconase Hayfever Nasal Spray, PL 02855/0064 (Omega Pharma Ltd) SNOMED Code:2945411000001101 Batch No Expiry [...]

The post Class 4 Medicines Defect Information: Beconase Hayfever Nasal Spray (Omega Pharma Ltd) appeared first on PSNC Website.

By |April 26th, 2023|Lexpos News|Comments Off on Class 4 Medicines Defect Information: Beconase Hayfever Nasal Spray (Omega Pharma Ltd)

April 2023 Price Concessions 3rd Update

The Department of Health and Social Care (DHSC) has today (25/04/2023) granted the following list of price concessions for April 2023: Drug Pack size Price concession Buprenorphine 8mg sublingual tablets sugar free 7 £4.41 Calcipotriol 0.005% / Betamethasone dipropionate 0.05% ointment 30 £9.23 Carbocisteine 375mg capsules 120 £7.24 Chloramphenicol 1% eye ointment 4 £5.20 Chlorpromazine [...]

The post April 2023 Price Concessions 3rd Update appeared first on PSNC Website.

By |April 25th, 2023|Lexpos News|Comments Off on April 2023 Price Concessions 3rd Update